Lead institution of the national rare-disease care network
2019–Leads the national rare-disease care network with an MDT mechanism for difficult and rare tumors, providing a national-level diagnostic pathway for complex cases.
Back to home
Directly under NHC · Consistently China’s top-ranked general hospital
Peking Union Medical College Hospital
Pancreatic cancerOvarian cancerBrain tumorGastric cancer
Established
1921
Beds
2,000+
Annual Volume
65,000+
Beijing
China’s national platform for complex diseases — the ultimate referral destination for rare tumors and difficult cases.
About the Hospital
Peking Union Medical College Hospital has ranked first in the Fudan comprehensive hospital ranking for many consecutive years and is renowned for diagnosing and treating difficult and rare diseases. Its medical oncology, general surgery and OB-GYN departments enjoy national reputations for complex and rare tumors.
The hospital hosts a national key laboratory for rare diseases and national capacity programs for difficult conditions — serving as the nationwide referral destination for “final diagnoses”.
Hospital Strengths
01The referral endpoint for rare and difficult tumors
Neuroendocrine tumors, cancers of unknown primary and rare gynecologic tumors — cases “undiagnosable elsewhere” — receive authoritative diagnoses here.
02Top-ranked comprehensive strength
Top-ranked critical care, anesthesia and medical subspecialties provide the strongest support for perioperative and comorbidity management of complex cancer patients.
03Distinctive neuroendocrine tumor program
The NET program run jointly by gastroenterology and general surgery is nationally known; pivotal studies of drugs such as surufatinib were conducted here.
Key Departments
Medical OncologyGeneral SurgeryOB-GYNThoracic SurgeryGastroenterologyRadiation Oncology
Coordinated Treatment Directions
- 01Definitive diagnosis of rare and difficult tumors
- 02MDT care for neuroendocrine tumors
- 03Diagnostic pathways for cancer of unknown primary
- 04Integrated management of cancer with complex comorbidities
Officially Reported Treatment Milestones
Benchmark MDT consultations for difficult and critical tumors
2015–Its MDT consultations for difficult tumors such as pancreatic and neuroendocrine cancers rank among the nation’s busiest, receiving complex referrals nationwide and forming the “PUMCH approach”.
Accreditations & Platforms
- Core hospital of the national complex-case capability program
- #1 in Fudan China Hospital Ranking for years